This is a framework agreement for the supply of pharmaceuticals. Due to space limitations, detailed descriptions and quantities related to the framework agreement and subsequent contracts are specified in the Terms of Reference and the list of lots included in this documentation, excluding VAT. The
Contract awarded. Originally published 10 months ago.
This framework agreement is for the supply of medications related to oncology, rare diseases, hemophilia, endocrine disorders, diabetes, HIV/AIDS, and infant formula. Detailed descriptions and quantities of the medications required are specified in the terms of reference and the list of lots include
This contract involves the supply of medical equipment, medical devices, and office supplies. Suppliers can request clarifications until 19 days before the deadline for submitting offers. The contracting authority will respond clearly and completely to all clarification requests on the 11th day befo
This is a framework agreement for the supply of laboratory reagents. Suppliers can request clarifications until 19 days before the deadline for submitting offers. The contracting authority will respond clearly and completely to all clarification requests on the 11th day before the submission deadlin
This procurement opportunity involves the supply of essential pharmaceutical products necessary for patient treatment. The absence of these products poses a significant risk to patient health. The contract will cover the purchase of medications in specified forms and quantities as outlined in the te
Supply non-clinical consumables including forms, labels, and packaging for pathology and primary care services.
Procurement of RSV immunisation vaccine products for adult populations, scheduled for 2028.
Procurement for meningococcal ACWY vaccine supply in 2027 from qualified manufacturers or distributors.
Procurement opportunity for MMR vaccine supply with anticipated delivery timeline of 2027.
